Cytovance

**ljbab728** · 01-28-2014, 01:36 PM

There isn't a mention here of new employees but this is obviously a growing business.

Cytovance Biologics breaks ground on GMP Warehouse and Manufacturing Operations facility

01/28/2014
Oklahoma City, OK -- Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, broke ground on an expansion facility to contain both manufacturing operations and GMP warehousing. The multi-million dollar capital investment project is being built by Capstone Construction and is expected to be completed by June 2014.

Cytovance is rapidly growing and expanding its capabilities in the areas of Microbial, Mammalian, and Fill Finish Operations with the addition of a new 1000L Microbial Fermenter, an Automated Fill/Finish machine, and a 2500L stainless steel bioreactor. The increase in scale and service offerings at our existing facilities identified the need to locate a new building to house our GMP warehousing and future manufacturing expansions. Cytovance selected a construction site two miles north of its current campus. The new facility located at 3500 N. Santa Fe will house 20,000 square feet of climate controlled and monitored GMP warehouse space and 10,000 square feet of dedicated space for existing and future Manufacturing Operations. Initially, this cleanroom space will be used for weighing and dispensing activities.

“Our new GMP warehouse will support incoming and outgoing supply chain activities and provide full segregation between incoming, quarantine, and released materials,” explained Don Wuchterl, Senior Vice President of Manufacturing Operations. “The additional manufacturing space will provide Cytovance with future expansion space to quickly meet our clients’ contract manufacturing requirements.”

In 2013, Cytovance Biologics was recognized as one of the fastest growing companies in Oklahoma City by the Greater Oklahoma City Chamber of Commerce. This expansion positions Cytovance to meet customer demands for both mammalian and microbial services. The company continues to provide analytical method development and process development for all phases of clinical trials and commercialization. Cytovance offers regulatory expertise to support validation and commercial launch for therapeutic proteins, recombinant proteins and monoclonal antibodies.

About Cytovance Biologics

Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services from its Oklahoma City state-of-the-art facilities.

Learn more about Cytovance Biologics at Cytovance Biologics | GMP Manufacturing | Contract Manufacturing.

It was discussed previously in the Research Park thread about 8 years ago.

http://www.okctalk.com/general-civic...ster-plan.html

**Plutonic Panda** · 06-26-2014, 01:23 PM

SAN DIEGO — The 2014 Biotechnology Industry Organization convention is a whirlwind of potential success for Darren Head, president and CEO of Oklahoma City-based Cytovance Biologics Inc. Prospective customers are filling up his calendar and keeping the Cytovance exhibition space buzzing.

“We’ve had more leads in our first day than in all the previous BIO shows combined,” Head said Wednesday morning just after completing the first business meeting of the day at a conference area located in the Cytovance booth space.

“It’s been crazy for us,” Head said. “I don’t know if it’s just the timing or the way the company’s growing or what’s going on. But it’s a lot of activity.”

Founded in 2003 by former executives of Novazyme Pharmaceuticals, Cytovance delivers a broad menu of specialized contract biological manufacturing services that help companies such as Oklahoma City’s Selexys Pharmaceuticals manufacture drugs for clinical trials.

The company has grown at a phenomenal pace since Head became its chief executive just over six years ago. It has grown from 30 employees to 135, many of them highly paid scientists.

Revenue is almost 20 times the $1.5 million generated in 2008. New, larger bioreactors have been installed in the company’s 44,000 square foot manufacturing facility at the University Research Park. Manufacturing capabilities have expanded, as well.

“We’re profitable, moving quickly to commercialization,” Head said. “We hope to have our first commercial product coming down the pipeline. We developed it for another company. It’s pretty exciting.”

Cytovance maintains its own exhibition space apart from the OKBio booth at the BIO show, largely because it wants to have a presence among its competitors in the contract manufacturing industry at the show.

- Oklahoma City's Cytovance sees whirlwind of potential success at BIO convention | News OK

This is nice...